España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
BriaCell Therapeutics
BCTX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.789000
0.19
31.00%
At close: -
$0.789600
0.0006
0.08%
After Hours: 7:59 PM EDT
Get Report
Comment
BriaCell Therapeutics (BCTX) Forecast
News
Earnings
BriaCell Therapeutics (BCTX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for BriaCell Therapeutics (NASDAQ:BCTX) Stock
BriaCell Therapeutics Stock (NASDAQ: BCTX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 21, 2024
BriaCell Therapeutics shares are trading high...
Benzinga Newsdesk
Briacell Therapeutics Has Dosed The First Pat...
Benzinga Newsdesk
Friday, November 08, 2024
BriaCell Therapeutics Reports Preclinical Dat...
Benzinga Newsdesk
Tuesday, October 15, 2024
BriaCell Announces Update On Phase 3 Clinical...
Benzinga Newsdesk
Thursday, October 03, 2024
HC Wainwright & Co. Reiterates Buy on BriaCel...
Benzinga Newsdesk
Wednesday, October 02, 2024
Why JD.com Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Tuesday, October 01, 2024
BriaCell Therapeutics shares are trading lowe...
Benzinga Newsdesk
BriaCell Therapeutics Announces $5M Offering ...
Benzinga Newsdesk
Thursday, September 19, 2024
HC Wainwright & Co. Maintains Buy on BriaCell...
Benzinga Newsdesk
Wednesday, September 18, 2024
BriaCell Therapeutics shares are trading high...
Benzinga Newsdesk
BriaCell Therapeutics Announced US FDA Author...
Benzinga Newsdesk
Wednesday, September 11, 2024
Nasdaq Surges Over 200 Points; US Crude Oil Stocks Increase
Avi Kapoor
HC Wainwright & Co. Reiterates Buy on BriaCel...
Benzinga Newsdesk
BriaCell Therapeutics Announces $8.5M Best-Ef...
Benzinga Newsdesk
Crude Oil Surges 2.5%; Rentokil Initial Shares Plunge
Avi Kapoor
Why Is Breast Cancer-Focused BriaCell Therapeutics Stock Trading Over 100% On Wednesday
Vandana Singh
BriaCell Therapeutics Shares Halted On Circui...
Benzinga Newsdesk
Dow Tumbles 350 Points; US Inflation Rate Slows In August
Avi Kapoor
BriaCell Therapeutics Shares Resume Trading
Benzinga Newsdesk
BriaCell Therapeutics Shares Halted On Circui...
Benzinga Newsdesk
BriaCell Therapeutics Shares Resume Trade
Benzinga Newsdesk
BriaCell Therapeutics Shares Halted On Circui...
Benzinga Newsdesk
Market-Moving News for September 11th
Benzinga Newsdesk
BriaCell Therapeutics shares are trading high...
Benzinga Newsdesk
BriaCell Announces Phase 2 Data Showing Media...
Benzinga Newsdesk
Tuesday, September 10, 2024
BriaCell Therapeutics Says Received Positive ...
Benzinga Newsdesk
Thursday, July 18, 2024
BriaCell Reports Extended Progression-Free Su...
Benzinga Newsdesk
Tuesday, June 04, 2024
HC Wainwright & Co. Reiterates Buy on BriaCel...
Benzinga Newsdesk
Monday, June 03, 2024
BriaCell Presents Clinical Efficacy Data Of R...
Benzinga Newsdesk
Thursday, May 30, 2024
BriaCell Starts Patient Enrollment In First-i...
Benzinga Newsdesk
Tuesday, May 28, 2024
BriaCell Therapeutics Announces Clinical Supp...
Benzinga Newsdesk
Friday, May 24, 2024
BriaCell Doubles Progression-Free-Survival An...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on BriaCel...
Benzinga Newsdesk
Wednesday, May 15, 2024
BriaCell Therapeutics shares are trading lowe...
Benzinga Newsdesk
BriaCell Therapeutics Announces Pricing Of $5...
Benzinga Newsdesk
Wednesday, April 10, 2024
BriaCell 2024 AACR Preclinical Poster Confirm...
Benzinga Newsdesk
Tuesday, April 09, 2024
BriaCell Highlights Data For Antibody-Drug Co...
Benzinga Newsdesk
Thursday, March 07, 2024
BriaCell Receives And Executes Letter Of Inte...
Benzinga Newsdesk
Wednesday, March 06, 2024
BriaCell To Present Clinical Data In Central ...
Benzinga Newsdesk
Tuesday, February 27, 2024
BriaCell Provides Update On Alleged Illegal T...
Benzinga Newsdesk
Wednesday, February 07, 2024
BriaCell Reports Prelim Disease Control Rate ...
Benzinga Newsdesk
Monday, January 22, 2024
Briacell Therapeutics Filed For Mixed Shelf Offering Of Up To $200M
Charles Gross
Thursday, January 04, 2024
BriaCell Images Confirm Robust Anti-Tumor Act...
Benzinga Newsdesk
Thursday, December 28, 2023
HC Wainwright & Co. Reiterates Buy on BriaCel...
Benzinga Newsdesk
BriaCell Reports 71% Central Nervous System R...
Benzinga Newsdesk
Wednesday, December 20, 2023
BriaCell Therapeutics' Cancer Drug Shows Preliminary Survival, Clinical Benefit In Pretreated Patients
Vandana Singh
BriaCell Therapeutics Reports Preliminary Sur...
Benzinga Newsdesk
Wednesday, December 06, 2023
BriaCell Highlights Outstanding Topline Survi...
Benzinga Newsdesk
BriaCell 2023 SABCS Posters Confirm Activatio...
Benzinga Newsdesk
Friday, November 03, 2023
BriaCell Reports Unprecedented Anti-Tumor Act...
Benzinga Newsdesk
Show More